Abstract | STUDY OBJECTIVE: DESIGN: Retrospective review. SETTING: An academic tertiary care hospital. PATIENTS: INTERVENTION: RESULTS: Outcome as defined by recurrence of effusion was determined by blinded examination of all postpleurodesis chest radiographs. We identified 58 cases of malignant pleural effusion in which small-bore catheters were used and 44 in which large-bore chest tubes were used. The majority of patients had breast (n = 56, 55%) or lung cancer (n = 29, 28%). The median age was 65 years. Fifty-nine patients were actively being treated with chemotherapy at the time of pleurodesis. The following sclerosing agents were used: talc, 27 (26%); tetracycline, 72 (70%); bleomycin, 2 (2%); and interferon, 1 (1%). Actuarial probabilities of recurrence at 6 weeks and 4 months were 45% and 53% for the small tubes vs 45% and 51% for the large tubes. Univariate and multivariate analyses failed to demonstrate that tube size had any influence on the rate of recurrence. CONCLUSIONS: We were unable to detect any major differences in outcomes with the use of either size of chest tube. Our study suggests that small-bore catheters may be effective in the treatment of malignant pleural effusions and deserve further evaluation in prospectively designed trials.
|
Authors | W Parulekar, G Di Primio, F Matzinger, C Dennie, G Bociek |
Journal | Chest
(Chest)
Vol. 120
Issue 1
Pg. 19-25
(Jul 2001)
ISSN: 0012-3692 [Print] United States |
PMID | 11451810
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Interferon Type I
- Sclerosing Solutions
- Bleomycin
- Talc
- Tetracycline
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Bleomycin
- Breast Neoplasms
(complications)
- Chest Tubes
(adverse effects)
- Drainage
(adverse effects, instrumentation)
- Female
- Humans
- Interferon Type I
- Lung Neoplasms
(complications)
- Male
- Middle Aged
- Pleural Effusion, Malignant
(mortality, therapy)
- Pleurodesis
- Probability
- Recurrence
- Retrospective Studies
- Sclerosing Solutions
- Sclerotherapy
(adverse effects)
- Survival Rate
- Talc
- Tetracycline
|